HSP90 interacting with IRS-2 is involved in cAMP-dependent potentiation of IGF-I signals in FRTL-5 cells

Molecular and Cellular Endocrinology

Volumn 344, Issue 1-2, 2011, Pages 81-89

  Fukushima, Toshiaki ^a,b   Okajima, Hiroshi ^a   Yamanaka, Daisuke ^a   Ariga, Miyako ^a   Nagata, Shinji ^a   Ito, Akihiro ^c   Yoshida, Minoru ^c   Asano, Tomoichiro ^b   Chida, Kazuhiro ^a   Hakuno, Fumihiko ^a   Takahashi, Shin Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Japan Science and Technology Agency   (Japan)

Author keywords

CAMP; FRTL 5 cells; HSP90; IGF I; IRS 2; Phosphorylation

Indexed keywords

ALKALINE PHOSPHATASE; CHAPERONE; CYCLIC AMP; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; INSULIN RECEPTOR; SERINE; SMALL INTERFERING RNA; SOMATOMEDIN; THREONINE; THYROTROPIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; THYROID CELL;

ANIMALS; CELL LINE; CYCLIC AMP; GENE KNOCKDOWN TECHNIQUES; HSP90 HEAT-SHOCK PROTEINS; IMMUNOPRECIPITATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; PHOSPHORYLATION; PROTEIN BINDING; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84860388987     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.06.029     Document Type: Article

References (37)

1. Adams T.E., McKern N.M., Ward C.W. Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor. Growth Factors 2004, 22:89-95.
2. Ariga M., Nedachi T., Akahori M., Sakamoto H., Ito Y., Hakuno F., Takahashi S.I. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Biochem. J. 2000, 348:409-416.
3. Bagatell R., Beliakoff J., David C.L., Marron M.T., Whitesell L. Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin. Int. J. Cancer 2005, 113:179-188.
4. Boehm A.K., Seth M., Mayr K.G., Fortier L.A. Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes. Arthritis Rheum 2007, 56:2335-2343.
5. Boura-Halfon S., Zick Y. Serine kinases of insulin receptor substrate proteins. Vitam. Horm. 2009, 80:313-349.
6. Caplan A.J., Mandal A.K., Theodoraki M.A. Molecular chaperones and protein kinase quality control. Trends Cell Biol. 2007, 17:87-92.
7. Dupont J., Le Roith D. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol. Pathol. 2001, 54:149-154.
8. Fox E.M., Andrade J., Shupnik M.A. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 2009, 74:622-627.
9. Fukushima T., Nedachi T., Akizawa H., Akahori M., Hakuno F., Takahashi S.I. Distinct modes of activation of phosphatidylinositol 3-kinase in response to cyclic adenosine 3', 5'-monophosphate or insulin-like growth factor I play different roles in regulation of cyclin D1 and p27Kip1 in FRTL-5 cells. Endocrinology 2008, 149:3729-3742.
10. Fukushima T., Arai T., Ariga-Nedachi M., Okajima H., Ooi Y., Iijima Y., Sone M., Cho Y., Ando Y., Kasahara K., Ozoe A., Yoshihara H., Chida K., Okada S., Kopchick J.J., Asano T., Hakuno F., Takahashi S.I. Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases. Biochem. Biophys. Res. Commun. 2011, 404:767-773.
11. Garcia-San Frutos M., Fernandez-Agullo T., De Solis A.J., Andres A., Arribas C., Carrascosa J.M., Ros M. Impaired central insulin response in aged Wistar rats: role of adiposity. Endocrinology 2007, 148:5238-5247.
12. Hochbaum D., Hong K., Barila G., Ribeiro-Neto F., Altschuler D.L. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis. J. Biol. Chem. 2008, 283:4464-4468.
13. Jhala U.S., Canettieri G., Screaton R.A., Kulkarni R.N., Krajewski S., Reed J., Walker J., Lin X., White M., Montminy M. CAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 2003, 17:1575-1580.
14. Kane S., Sano H., Liu S.C., Asara J.M., Lane W.S., Garner C.C., Lienhard G.E. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 2002, 277:22115-22118.
15. Kazlauskas A. The priming/completion paradigm to explain growth factor-dependent cell cycle progression. Growth Factors 2005, 23:203-210.
16. Kimura T., Van Keymeulen A., Golstein J., Fusco A., Dumont J.E., Roger P.P. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr. Rev. 2001, 22:631-656.
17. Lim M.J., Choi K.J., Ding Y., Kim J.H., Kim B.S., Kim Y.H., Lee J., Choe W., Kang I., Ha J., Yoon K.S., Kim S.S. RhoA/Rho Kinase Blocks Muscle Differentiation via Serine Phosphorylation of Insulin Receptor Substrate-1 and -2. Mol. Endocrinol. 2007, 21:2282-2293.
18. Medina D.L., Santisteban P. Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur. J. Endocrinol. 2000, 143:161-178.
19. Mitsiades C.S., Mitsiades N.S., McMullan C.J., Poulaki V., Kung A.L., Davies F.E., Morgan G., Akiyama M., Shringarpure R., Munshi N.C., Richardson P.G., Hideshima T., Chauhan D., Gu X., Bailey C., Joseph M., Libermann T.A., Rosen N.S., Anderson K.C. Antimyeloma activity of heat shock protein-90 inhibition. Blood 2006, 107:1092-1100.
20. Miyagi E., Braga-Basaria M., Hardy E., Vasko V., Burman K.D., Jhiang S., Saji M., Ringel M.D. Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells. Mol. Carcinog. 2004, 41:98-107.
21. Nedachi T., Akahori M., Ariga M., Sakamoto H., Suzuki N., Umesaki K., Hakuno F., Takahashi S.I. Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3', 5'-monophosphate-dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells. Endocrinology 2000, 141:2429-2438.
22. Ogihara T., Shin B.C., Anai M., Katagiri H., Inukai K., Funaki M., Fukushima Y., Ishihara H., Takata K., Kikuchi M., Yazaki Y., Oka Y., Asano T. Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with phosphatidylinositol 3-kinase in skeletal muscle cells. J. Biol. Chem. 1997, 272:12868-12873.
23. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol. Life Sci. 2002, 59:1640-1648.
24. Poulaki V., Mitsiades C.S., Kotoula V., Tseleni-Balafouta S., Ashkenazi A., Koutras D.A., Mitsiades N. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am. J. Pathol. 2002, 161:643-654.
25. Rubini M., Hongo A., D'Ambrosio C., Baserga R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res. 1997, 230:284-292.
26. Saji M., Kohn L.D. Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3', 5'-monophosphate signal action. Endocrinology 1991, 128:1136-1143.
27. Sano H., Liu S.C., Lane W.S., Piletz J.E., Lienhard G.E. Insulin receptor substrate 4 associates with the protein IRAS. J. Biol. Chem. 2002, 277:19439-19447.
28. Suh J.M., Song J.H., Kim D.W., Kim H., Chung H.K., Hwang J.H., Kim J.M., Hwang E.S., Chung J., Han J.H., Cho B.Y., Ro H.K., Shong M. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J. Biol. Chem. 2003, 278:21960-21971.
29. Takahashi S.I., Conti M., Van W.J. Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s). Endocrinology 1990, 126:736-745.
30. Takahashi S.I., Conti M., Prokop C., Van Wyk J.J., Earp H.S. Thyrotropin and insulin-like growth factor I regulation of tyrosine phosphorylation in FRTL-5 cells. Interaction between cAMP-dependent and growth factor-dependent signal transduction. J. Biol. Chem. 1991, 266:7834-7841.
31. Tortosa E., Santa-Maria I., Moreno F., Lim F., Perez M., Avila J. Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein. J. Alzheimers Dis. 2009, 17:319-325.
32. Tramontano D., Moses A.C., Veneziani B.M., Ingbar S.H. Adenosine 3', 5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. Endocrinology 1988, 122:127-132.
33. Van Wyk J.J., Conti M., Del Monte P., Takahashi S.I. The role of somatomedins in the growth and function of endocrine tissues. Dev. Endocrinol. 1990, 127-140. Raven Press, New York. P.C. Sizonenko, M.L. Aubert (Eds.).
34. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E413-E422.
35. Xu Y., Singer M.A., Lindquist S. Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proc. Natl. Acad. Sci. USA 1999, 96:109-114.
36. Yoshikawa N., Nemoto T., Satoh S., Maruta T., Yanagita T., Chosa E., Wada A. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells. Neurochem. Int. 2010, 56:42-50.
37. Zakarija M., McKenzie J.M. Variations in the culture medium for FRTL5 cells: effects on growth and iodide uptake. Endocrinology 1989, 125:1253-1259.